Hyewon Nam
About Hyewon Nam
Hyewon Nam is a HEMA Specialist at Boston Scientific with a background in data science and statistics, having previously worked at Hanmi Pharmaceuticals, IQVIA, and IMS Health.
Current Position at Boston Scientific
Hyewon Nam is currently a HEMA Specialist at Boston Scientific. She has been in this role since 2020, contributing her expertise in handling Health Economics and Market Access (HEMA) responsibilities. Her role includes designing outcome research protocols, creating statistical plans, analyzing claim data, and reporting the outcomes comprehensively.
Former Role at Hanmi Pharmaceuticals
Before joining Boston Scientific, Hyewon Nam was a Data Scientist at Hanmi Pharmaceuticals from 2018 to 2020. During her tenure, she conducted a longitudinal observational study by analyzing Health Insurance Review and Assessment (HIRA) and National Health Insurance Service (NHIS) claim data. Her analysis provided valuable insights that assisted internal teams and symposium speakers.
Experience at IQVIA
Hyewon Nam served as a Data Analyst at IQVIA from 2017 to 2018. In this role, she was responsible for providing data analyses to meet internal and client-specific needs. Her ability to analyze data effectively played a crucial role in supporting various projects and initiatives.
Academic Background
Hyewon Nam graduated from Brigham Young University, where she studied Statistics and earned her bachelor's degree. Her academic training from 2011 to 2016 laid a strong foundation for her subsequent roles in data analysis and statistics in the healthcare sector.
Published Work on Amozartan
Hyewon Nam demonstrated her expertise by forming a detailed plan to analyze HIRA sample data to showcase the benefits of Amozartan. Her efforts culminated in the publication of the 'Amozartan Fact Sheet' on its 10th anniversary, highlighting the drug's strengths through thorough data analysis.